Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology Indian Medical PG Practice Questions and MCQs

Question 71: What is the topically used non-selective alpha-agonist in glaucoma?

A. Bimatoprost
B. Dorzolamide
C. Brimonidine
D. Dipivefrine (Correct Answer)

Explanation: **Explanation:** **Dipivefrine** is the correct answer because it is a prodrug of **Epinephrine**, which is a **non-selective alpha and beta-adrenergic agonist**. **Mechanism of Action:** Dipivefrine is converted into epinephrine by esterases in the cornea. It lowers intraocular pressure (IOP) through a dual mechanism: 1. **Initial effect:** Increases aqueous outflow through the trabecular meshwork (alpha-1 effect). 2. **Secondary effect:** Decreases aqueous production (alpha-2 effect) and increases uveoscleral outflow. As a prodrug, it is more lipophilic than epinephrine, allowing for better corneal penetration and fewer systemic side effects. **Analysis of Incorrect Options:** * **A. Bimatoprost:** This is a **Prostamide (Prostaglandin analogue)**. It is currently the first-line treatment for glaucoma and works by increasing uveoscleral outflow. * **B. Dorzolamide:** This is a topical **Carbonic Anhydrase Inhibitor (CAI)**. It reduces IOP by decreasing the production of aqueous humor from the ciliary body epithelia. * **C. Brimonidine:** While an alpha-agonist, it is **highly selective for Alpha-2 receptors**. It is not non-selective. It reduces aqueous production and increases uveoscleral outflow. **High-Yield Clinical Pearls for NEET-PG:** * **Adrenochrome deposits:** Epinephrine/Dipivefrine can cause black pigment deposits in the conjunctiva. * **Cystoid Macular Edema (CME):** Epinephrine compounds are contraindicated in **aphakic** patients as they can induce CME. * **Mydriasis:** Unlike Brimonidine, Dipivefrine can cause pupillary dilation; hence, it is contraindicated in angle-closure glaucoma. * **Drug of choice (DOC)** for primary open-angle glaucoma (POAG) is Prostaglandin analogues (e.g., Latanoprost).

Question 72: Steroids are contraindicated in which of the following conditions?

A. Phlyctenular conjunctivitis
B. Granular conjunctivitis
C. Mooren's ulcer
D. Dendritic ulcer (Correct Answer)

Explanation: **Explanation:** The correct answer is **Dendritic ulcer**, which is the hallmark of **Herpes Simplex Keratitis (HSK)**. **1. Why Dendritic Ulcer is the Correct Answer:** A dendritic ulcer is caused by active viral replication of the Herpes Simplex Virus (HSV) in the corneal epithelium. **Steroids are strictly contraindicated** during the active epithelial stage because they inhibit the local immune response and promote viral replication. This can lead to the expansion of the ulcer into a large, geographic ulcer and may result in corneal perforation. Steroids also increase the risk of secondary fungal infections and steroid-induced glaucoma. **2. Analysis of Incorrect Options:** * **Phlyctenular conjunctivitis:** This is a delayed hypersensitivity reaction (Type IV) to endogenous antigens (like Tubercular protein). Topical steroids are the **treatment of choice** to suppress this allergic response. * **Granular conjunctivitis (Trachoma):** While primarily treated with antibiotics (Azithromycin), steroids are not contraindicated; they may occasionally be used to manage symptomatic follicular inflammation. * **Mooren's ulcer:** This is an idiopathic, peripheral ulcerative keratitis of autoimmune origin. Topical and systemic **steroids are a mainstay of treatment** to halt the progressive destruction of the corneal stroma. **3. NEET-PG High-Yield Pearls:** * **The "Steroid Exception" in HSK:** While contraindicated in *epithelial* (dendritic) keratitis, steroids are the treatment of choice for *stromal* (disciform) keratitis, provided they are covered by prophylactic antiviral drops. * **Rose Bengal Stain:** This stain is specific for the "devitalized cells" at the base and margins of a dendritic ulcer. * **Side Effects of Long-term Steroids:** Always remember the "Two C's"—**C**ataract (Posterior Subcapsular) and **C**upping (Glaucoma).

Question 73: Bull's eye lesion in the macula is seen with which of the following medications?

A. Chloroquine (Correct Answer)
B. Primaquine
C. Quinine
D. Sulfamethoxazole

Explanation: **Explanation:** **Chloroquine (and Hydroxychloroquine)** are the classic causes of **Bull’s eye maculopathy**. These drugs have a high affinity for melanin and accumulate in the **Retinal Pigment Epithelium (RPE)**. The toxicity manifests as a central area of RPE atrophy (pale) surrounded by a ring of spared RPE, which is further encircled by another ring of atrophy, giving the characteristic "Bull's eye" appearance on fundoscopy. This leads to progressive, irreversible visual field loss (scotomas). **Analysis of Incorrect Options:** * **Primaquine:** An antimalarial used for radical cure (liver stages); it is primarily associated with hematologic side effects like hemolysis in G6PD deficiency, not retinal toxicity. * **Quinine:** Known for causing **"Quinine Amblyopia."** Acute toxicity leads to sudden vision loss, pupillary abnormalities, and marked arteriolar narrowing (cherry red spot may be seen), but not a Bull's eye lesion. * **Sulfamethoxazole:** A sulfonamide that can cause hypersensitivity reactions (Stevens-Johnson Syndrome) or acute transient myopia/angle-closure glaucoma due to ciliary body edema, but it is not associated with macular pigmentary changes. **High-Yield Clinical Pearls for NEET-PG:** * **Other causes of Bull’s eye maculopathy:** Stargardt’s disease (most common genetic cause), Cone dystrophy, and Chronic Thioridazine toxicity. * **Screening:** The most sensitive tests for early detection are **Automated Visual Fields (10-2)** and **Spectral Domain OCT (SD-OCT)**, which shows the "Flying Saucer" sign (loss of outer retinal layers). * **Dosage:** Toxicity risk increases significantly when the daily dose of Hydroxychloroquine exceeds **5 mg/kg** of real body weight.

Question 74: Latanoprost is a relatively newer agent. Which of the following statements is true regarding this agent?

A. It is a PGF2a derivative used in glaucoma. (Correct Answer)
B. It is a selective a1 blocker used in benign hypertrophy of the prostate.
C. It is a 5a reductase inhibitor used to reduce the size of an enlarged prostate gland.
D. It is a PGE2 analogue used intravaginally for cervical priming.

Explanation: **Explanation:** **Latanoprost** is a high-yield topic in Ophthalmic Pharmacology. It is a **Prostaglandin F2α (PGF2α) analogue** that acts as a selective agonist at the FP receptor. It is primarily used as a first-line treatment for **Open-Angle Glaucoma (OAG)** and Ocular Hypertension. Its mechanism of action involves increasing the **uveoscleral outflow** of aqueous humor, thereby reducing intraocular pressure (IOP). **Analysis of Options:** * **Option A (Correct):** Latanoprost is indeed a PGF2α derivative. Unlike traditional drugs (like Beta-blockers) that decrease aqueous production, Latanoprost enhances the drainage through the unconventional uveoscleral pathway. * **Option B (Incorrect):** Selective α1 blockers (e.g., Tamsulosin, Alfuzosin) are used for BPH, but Latanoprost has no action on adrenergic receptors. * **Option C (Incorrect):** 5α-reductase inhibitors (e.g., Finasteride, Dutasteride) prevent the conversion of testosterone to DHT. Latanoprost is not a hormonal modulator. * **Option D (Incorrect):** PGE2 analogues used for cervical priming/induction of labor include **Dinoprostone**. While Latanoprost is a prostaglandin, its specific PGF2α structure and formulation are dedicated to ophthalmic use. **High-Yield Clinical Pearls for NEET-PG:** 1. **Side Effects:** The most characteristic side effects are **increased iris pigmentation** (permanent browning), **hypertrichosis** (increased eyelash growth/thickness), and **prostaglandin-associated periorbitopathy**. 2. **Dosing:** It is administered as **once-daily** eye drops (usually at night), which ensures better patient compliance compared to multi-dose regimens. 3. **Contraindication:** It should be avoided in patients with active **uveitis** or **cystoid macular edema (CME)** as it may exacerbate inflammation.

Question 75: Topical Pilocarpine 1% administration failed to produce pupillary constriction in a patient with a large dilated pupil. What is the most probable reason for this failure?

A. Adie's tonic pupil
B. Uncal herniation
C. Pharmacological blockade (Correct Answer)
D. Diabetic IIIrd cranial nerve palsy

Explanation: **Explanation:** The clinical scenario describes a **Pilocarpine Challenge Test**, used to differentiate the causes of a fixed, dilated pupil (mydriasis). **1. Why Pharmacological Blockade is correct:** Pilocarpine is a direct-acting parasympathomimetic (cholinergic agonist) that acts directly on the muscarinic receptors of the iris sphincter muscle. In cases of **pharmacological blockade** (accidental or intentional instillation of atropine, tropicamide, or scopolamine), the muscarinic receptors are physically occupied and blocked. Therefore, even a 1% or 2% concentration of Pilocarpine cannot bind to the receptors, and the pupil fails to constrict. **2. Why other options are incorrect:** * **Adie’s Tonic Pupil:** This is due to post-ganglionic denervation of the ciliary ganglion. The iris sphincter becomes hypersensitive to cholinergic drugs (**Denervation Supersensitivity**). It will constrict even with very dilute Pilocarpine (0.125%), which would not affect a normal pupil. * **Uncal Herniation & Diabetic III Nerve Palsy:** Both involve damage to the IIIrd cranial nerve (pre-ganglionic). Since the iris sphincter muscle and its receptors remain intact and healthy, they will respond normally and **constrict** when 1% Pilocarpine is applied directly to the eye. **Clinical Pearls for NEET-PG:** * **The 1% Pilocarpine Test:** If the pupil constricts, the cause is neurological (III Nerve palsy). If it fails to constrict, the cause is pharmacological (atropine-like drugs) or structural (iris ischemia/trauma). * **Adie’s Pupil Diagnosis:** Use **0.125% Pilocarpine**. Constriction = Adie’s; No constriction = Normal pupil. * **Apraclonidine Test:** Used for Horner’s Syndrome (causes reversal of anisocoria).

Question 76: What is the most important action of beta-blockers in glaucoma?

A. Membrane stabilizing effect
B. Retinal neuron protecting effect
C. Decrease in the production of aqueous humor (Correct Answer)
D. Pupillary constriction

Explanation: ### Explanation **Correct Answer: C. Decrease in the production of aqueous humor** The primary mechanism of action of topical beta-blockers (e.g., Timolol, Betaxolol) in managing glaucoma is the **reduction of aqueous humor production**. **Mechanism:** Beta-adrenergic receptors (specifically $\beta_2$) are located on the non-pigmented epithelium of the **ciliary body**. Under normal physiological conditions, catecholamines stimulate these receptors to facilitate the secretion of aqueous humor. Beta-blockers antagonize these receptors, inhibiting the active secretion process, which leads to a decrease in intraocular pressure (IOP). --- ### Analysis of Incorrect Options: * **A. Membrane stabilizing effect:** This refers to a local anesthetic-like action. While some beta-blockers (like Propranolol) possess this, it is actually **undesirable** in ophthalmology because it causes corneal anesthesia, leading to a loss of the protective blink reflex and potential corneal ulcers. * **B. Retinal neuron protecting effect:** While "neuroprotection" is a goal in glaucoma management (often associated with Brimonidine or Memantine), it is not the *primary* or most important mechanism by which beta-blockers lower IOP. * **D. Pupillary constriction:** This is the mechanism of **Miotics** (e.g., Pilocarpine). Beta-blockers do not affect the sphincter pupillae or dilator muscles; therefore, they do not change pupil size or accommodation. --- ### NEET-PG High-Yield Pearls: * **Drug of Choice:** Timolol was traditionally the first-line treatment for Open Angle Glaucoma (now often replaced by Prostaglandin analogues). * **Cardiopulmonary Risks:** Even topical beta-blockers can be absorbed systemically via the nasolacrimal duct. They are **contraindicated** in patients with Bronchial Asthma, COPD, and Heart Block. * **Betaxolol:** It is a **selective $\beta_1$ blocker**. While it is safer for the lungs than Timolol, it is slightly less effective at lowering IOP because the ciliary body primarily contains $\beta_2$ receptors. * **Tip:** To minimize systemic absorption, advise patients to perform **punctal occlusion** for 2 minutes after instilling drops.

Question 77: Which is the fastest acting cycloplegic drug?

A. Atropine
B. Tropicamide (Correct Answer)
C. Cyclopentolate
D. Homatropine

Explanation: **Explanation:** The speed of onset of a cycloplegic drug is determined by its pharmacokinetics and its affinity for the muscarinic receptors in the ciliary muscle. **1. Why Tropicamide is correct:** Tropicamide is a synthetic derivative of tropic acid with the **fastest onset of action** among all cycloplegics and mydriatics. It reaches its peak mydriatic effect in 20–40 minutes and peak cycloplegic effect within **20–30 minutes**. Due to its rapid onset and short duration of action (4–6 hours), it is the drug of choice for routine fundus examinations. **2. Analysis of Incorrect Options:** * **Atropine (A):** It is the most potent cycloplegic but has the **slowest onset** (30–60 minutes for peak effect) and the longest duration (7–12 days). It is used primarily for refraction in children under 7 years or in cases of active uveitis. * **Cyclopentolate (C):** It has a rapid onset (25–75 minutes) and is the **drug of choice for cycloplegic refraction** in children and young adults, but it is slower than Tropicamide. * **Homatropine (D):** This is a semi-synthetic alkaloid with an intermediate onset (30–60 minutes) and duration (1–3 days). It is less potent than Atropine and is mainly used in the treatment of anterior uveitis to prevent synechiae. **High-Yield Clinical Pearls for NEET-PG:** * **Fastest Acting:** Tropicamide. * **Most Potent/Longest Acting:** Atropine. * **Drug of Choice (DOC) for Cycloplegic Refraction (Children):** Cyclopentolate. * **DOC for Refraction in Children <7 years/Accommodative Esotropia:** Atropine (Ointment is preferred over drops to prevent systemic toxicity). * **Mechanism:** All these drugs are **parasympatholytics** (Muscarinic antagonists) that block the M3 receptors in the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia).

Question 78: Which of the following is true regarding the ophthalmic use of topical retinoic acid?

A. Conjunctival melanoma
B. Naevus or congenital moles
C. Ocular-surface squamous neoplasm (Correct Answer)
D. Pterygium

Explanation: **Explanation** The correct answer is **C. Ocular-surface squamous neoplasm (OSSN)**. **Why it is correct:** Retinoids (Vitamin A derivatives) play a critical role in regulating the growth and differentiation of epithelial cells. In the context of **Ocular-surface squamous neoplasm (OSSN)**, topical retinoic acid (specifically All-trans retinoic acid or ATRA) acts by inducing cell cycle arrest and promoting the redifferentiation of neoplastic squamous cells back into normal epithelium. It is often used as an adjunctive or alternative therapy to surgical excision, or in combination with other topical chemotherapeutic agents like Mitomycin-C, 5-Fluorouracil, or Interferon alpha-2b. **Why other options are incorrect:** * **A & B (Conjunctival melanoma / Naevus):** These are melanocytic tumors (derived from melanocytes). Retinoic acid targets epithelial differentiation and is not an effective treatment for pigmented or melanocytic lesions. * **D (Pterygium):** While pterygium involves epithelial proliferation, the primary treatment is surgical excision (with autograft). Retinoic acid is not a standard or indicated treatment for pterygium. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Retinoids bind to nuclear receptors (RAR and RXR) to modulate gene expression. * **Other Ophthalmic Uses:** Topical Vitamin A is also used in **Bitot’s spots** and **Dry Eye Syndrome** (specifically to treat squamous metaplasia of the conjunctiva). * **OSSN Spectrum:** Includes conjunctival intraepithelial neoplasia (CIN) and invasive squamous cell carcinoma. * **Gold Standard for OSSN:** While topical therapy is gaining popularity, the traditional gold standard remains surgical excision with "no-touch" technique and wide margins (4mm).

Question 79: What is the drug of choice for CMV retinitis in patients with AIDS?

A. Acyclovir
B. Ganciclovir (Correct Answer)
C. Pentamidine
D. Cotrimoxazole

Explanation: **Explanation:** **CMV Retinitis** is the most common opportunistic ocular infection in patients with AIDS, typically occurring when the CD4+ T-lymphocyte count falls below 50 cells/µL. It is characterized by a "pizza-pie" or "cheese and ketchup" fundus appearance due to extensive retinal necrosis and hemorrhage. **Why Ganciclovir is the Correct Answer:** **Ganciclovir** is a nucleoside analogue that inhibits viral DNA polymerase. It is the established **drug of choice** for CMV retinitis. It can be administered intravenously, orally (Valganciclovir), or via intravitreal injections/implants. Valganciclovir (the prodrug) is now frequently used for both induction and maintenance therapy due to its high oral bioavailability. **Analysis of Incorrect Options:** * **A. Acyclovir:** While an antiviral, it is highly effective against Herpes Simplex (HSV) and Varicella-Zoster (VZV) but has **minimal activity** against CMV. * **C. Pentamidine:** This is an antiprotozoal agent used primarily to treat *Pneumocystis jirovecii* pneumonia (PCP) in AIDS patients, not viral infections. * **D. Cotrimoxazole:** This is the drug of choice for the prophylaxis and treatment of *Pneumocystis jirovecii* and *Toxoplasma gondii*, but it has no antiviral properties. **High-Yield Clinical Pearls for NEET-PG:** * **Alternative Drugs:** If Ganciclovir resistance occurs or if there is limiting bone marrow toxicity, **Foscarnet** or **Cidofovir** are used. * **Side Effects:** A classic side effect of Ganciclovir is **bone marrow suppression** (neutropenia/thrombocytopenia), whereas Foscarnet is known for **nephrotoxicity**. * **Fundus Appearance:** Look for "brushfire" borders or "pizza-pie" retinopathy in clinical vignettes. * **Immune Recovery Uveitis (IRU):** Be aware that starting HAART can lead to an inflammatory response in the eye as the immune system recovers.

Question 80: All of the following are true about antiglaucoma drugs except?

A. PGF2 α analogues increase uveoscleral outflow
B. Usage of Timolol is unsafe in infants (Correct Answer)
C. Apraclonidine can lead to lid retraction
D. Adrenaline can lead to conjunctival pigmentation

Explanation: ### Explanation The correct answer is **B**, as the statement "Usage of Timolol is unsafe in infants" is technically **false** (making it the "except" choice). While Timolol must be used with extreme caution, it is not strictly contraindicated or "unsafe" if used at lower concentrations (0.25%) with punctal occlusion. However, the drug of choice for pediatric glaucoma is usually surgery, and the most "unsafe" or strictly contraindicated drug in infants is actually **Brimonidine** (due to CNS depression and apnea). #### Analysis of Options: * **A. PGF2 α analogues increase uveoscleral outflow:** This is **true**. Latanoprost and Bimatoprost work by remodeling the extracellular matrix in the ciliary muscle, thereby increasing the non-conventional (uveoscleral) outflow. * **B. Usage of Timolol is unsafe in infants:** This is the **incorrect statement**. While beta-blockers can cause bradycardia or bronchospasm, they are used in pediatric practice with monitoring. The drug that is truly "unsafe" and contraindicated in children under 2 years is **Brimonidine**, as it crosses the blood-brain barrier. * **C. Apraclonidine can lead to lid retraction:** This is **true**. Apraclonidine is an alpha-agonist that stimulates Müller’s muscle, leading to widening of the palpebral fissure (lid retraction). * **D. Adrenaline can lead to conjunctival pigmentation:** This is **true**. Chronic use of adrenaline drops can lead to the formation of **adrenochrome deposits**, which appear as black, oxidized pigment spots in the conjunctiva. #### High-Yield Clinical Pearls for NEET-PG: * **Brimonidine Contraindication:** Always remember: Brimonidine = CNS depression/Apnea in infants. It is a favorite "except" question. * **Latanoprost Side Effects:** Increased iris pigmentation, hypertrichosis (thickening of lashes), and cystoid macular edema (CME). * **Drug of Choice (DOC):** * Primary Open Angle Glaucoma (POAG): Prostaglandin analogues. * Acute Angle Closure Glaucoma: IV Mannitol (to rapidly reduce IOP) and Acetazolamide. * **Timolol:** Avoid in patients with Asthma or Heart Block.

Practice by Chapter

Ocular Pharmacokinetics

Practice Questions

Anti-infective Agents

Practice Questions

Anti-inflammatory Drugs

Practice Questions

Antiglaucoma Medications

Practice Questions

Mydriatics and Cycloplegics

Practice Questions

Ocular Lubricants

Practice Questions

Anti-VEGF Agents

Practice Questions

Ocular Diagnostic Agents

Practice Questions

Anesthetics in Ophthalmology

Practice Questions

Preservatives and Their Effects

Practice Questions

Ocular Toxicology

Practice Questions

Novel Drug Delivery Systems

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free